Whitepapers

Case Study

Partnering with drug discovery service providers: challenges and solutions

Drug discovery contract research organizations (CROs) offer an established infrastructure and experience that offers promising paths forward for various research projects. However, partnering with a CRO also presents key challenges, and companies should consider three questions: How long until data is delivered? Will the quality of the data instill confidence in a critical go/no-go decision? […]

Download the Case Study
Case Study

Pairing the Right Small Molecule Library with Innovative High-Throughput Screening Creates More Therapeutic Opportunity

Finding an encouraging drug lead that selectively engages a target of interest is the result of several critical matches that lead to successful drug discovery programmes, including: Matching a small molecule library with an innovative assay technology Matching a primary screening platform with orthogonal assays to validate hits Matching a drug discovery company with a […]

Download the Case Study
Brochure

Cubis Laboratory Balances in Vaccine Research and Development

Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save millions of lives.   The continuous emergence of new diseases and concerns regarding safety, vaccine research and development became […]

Download the Brochure
App Note

Ready-to-go spheroids + media for drug discovery

More physiologically and pathologically relevant preclinical human liver models are needed for drug liver liability assessment and liver disease modeling. While Drug-Induced Liver Injury (DILI) remains a major safety concern, several recent high-profile NAFLD/NASH clinical trial failures further highlight this critically unmet need. With the advances in 3D culture, we and others have demonstrated the […]

Download the App Note
e-Book

Single-cell Sequencing 101: DNA & Multi-omics for Precision Medicine

Cancer is a complex disease that continuously evolves in response to environmental pressures. The dynamism and heterogeneity of tumours have significant clinical implications. In this eBook, we review how single-cell DNA sequencing and multi-omics are used to dissect clonal architecture, providing valuable insights for clinical strategies, disease modelling, and the development of cell and gene […]

Download the e-Book
Whitepaper

Batch-to-batch consistency: premium grade bioactive proteins

From basic to translational research and clinical applications, cell culture is an essential technique that underpins the generation of promising cell and gene therapies. Since the quality of cytokines and growth factors can significantly influence the properties and function of cultured cells, these bioactive proteins must be produced to the highest standards to ensure the same reproducible […]

Download the Whitepaper
Whitepaper

Weighing in Compliance with European Pharmacopoeia Chapter 2.1.7

European Pharmacopoeia (Ph. Eur.) General Chapter 2.1.7 Balances for Analytical Purposes was published in July 2021. Compliance with this chapter by January 1, 2022 is mandatory for any pharmaceutical company who manufactures in, or exports into, the European market.   Balances for Analytical Purposes aims to ensure quality control of medicines in European member states. The requirements of Ph. Eur. are similar […]

Download the Whitepaper
Brochure

Cubis Laboratory Balances in Vaccine Research and Development

Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save millions of lives. Along the continuous emergence of new diseases and concerns regarding safety, vaccine research […]

Download the Brochure
eBook

Antibody Discovery: From Target to Molecule

You’re about to embark on a journey of discovery. And like all journeys that are worthwhile, it’s far from linear. The process of antibody discovery and development into a clinical candidate is one full of twists, turns, roundabouts, and offshoots, yet one that an increasing number of researchers and companies, both small and large, have […]

Download the eBook
Whitepaper

An industry perspective by 20/15 Visioneers, a leading science and technology consulting firm

John Conway of 20/15 Visioneers tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective. Learn: The six high-level workflows a great BioELN must include What are the team personas who must get utility from a new BioELN The 3 key qualities necessary to have in place before seeking a BioELN […]

Download the Whitepaper